Background This study aimed to assess the risk of obstructive sleep apnea (OSA) in glaucoma patients using the STOP-BANG questionnaire at the King Abdulaziz University Hospital (KAUH), a tertiary care center in Saudi Arabia. Methodology This study used a cross-sectional telephone survey. Patients older than 18 years diagnosed with open-angle glaucoma, without a diagnosis of respiratory disease or steroid use, completed the STOP-BANG questionnaire, a validated tool to determine the risk for developing OSA. Patients with a score of 3 or more were considered at intermediate risk of OSA, and those with a score of 5 or more of the maximum 8 points were considered to have a high risk for moderate/severe OSA. Social demographic information and medical histories were collected from all patients using the medical record system of the KAUH. Results A total of 77 patients with glaucoma were included in the study. The mean STOP-BANG score was 3.40 ± 1.5; 27.3% of the patients had low risk of OSA, 36.4% had intermediate risk, and 36.4% had high risk. An evaluation of the OSA symptoms found snoring, tiredness, and observed apnea in 29.9%, 36.4%, and 14.3% of patients, respectively. The association between body mass index and STOP-BANG score was significant. Conclusions Our analysis and assessment of the association between glaucoma and OSA found no evidence that glaucoma patients are more likely to have OSA or develop more severe OSA than others. Therefore, we do not recommend systematic screening of glaucoma patients for OSA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582017 | PMC |
http://dx.doi.org/10.7759/cureus.18699 | DOI Listing |
Am Fam Physician
January 2025
Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada.
Vision loss affects more than 7 million Americans and impacts quality of life, independence, social functioning, and overall health. Common and dangerous conditions causing sudden vision loss include acute angle-closure glaucoma, retinal detachment, retinal artery occlusion, giant cell arteritis, and optic neuritis. Acute angle-closure glaucoma features ocular pain, headache, and nausea; treatment includes pilocarpine eye drops, oral or intravenous acetazolamide, and intravenous mannitol.
View Article and Find Full Text PDFAm J Ophthalmol Case Rep
December 2024
Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL, USA.
Purpose: To identify clinical features which may predict the angle status of a large cohort of NVG eyes at the time of diagnosis.
Observations: Chart review was performed for all NVG eyes from 2010 to 2022. Complete angle closure was defined as having >75 % PAS, partial angle closure as having 1-75 % PAS, and open angles as having 0 % PAS.
Am J Ophthalmol Case Rep
December 2024
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Purpose: To report a case of corneoscleral juvenile xanthogranuloma (JXG) with progressive anterior segment involvement refractory to topical steroids.
Observations: A 4-month-old male was referred for a new-onset subconjunctival lesion in the right eye. He was found to have a thickened, yellow corneoscleral lesion and hyphema, presumed to be ocular JXG.
Invest Ophthalmol Vis Sci
January 2025
Invest Ophthalmol Vis Sci
January 2025
Department of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, United States.
Purpose: Vascular impairments, including reduced capillary density (CD), impaired autoregulation capacity (Reg), and elevated intraocular pressure (IOP), have been identified as significant contributors to glaucomatous disease. This study implemented a theoretical model to quantify the impact of these impairments on retinal blood flow and oxygenation as intraluminal pressure (Pa) is varied.
Methods: A theoretical model of the retinal vasculature was used to simulate reductions in CD by 10% (early glaucoma) and 30% to 50% (advanced glaucoma), a range in autoregulation capacity from 0% (totally impaired) to 100% (totally functional), and normal (15 mm Hg) and elevated (25 mm Hg) levels of IOP.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!